MedTrace Logo

Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention

NCT06073106 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-04-11

No results posted yet for this study

Summary

The aging population and its accompanying burden from non-communicable chronic diseases predicts an increasing impact imposed by frailty on healthcare systems. This is due to a lack of normative data for older adults and reliable risk stratification methods to develop effective approaches to the prevention of frailty.

In this study, the investigators plan to form a common dataset for phenotype identification, risk stratification of frailty and its targeted treatment plans in the at-risk and mildly frail population.

Conditions

Sponsors & Collaborators

  • Woodlands Health (WH)

    collaborator UNKNOWN

  • Rehabilitation Research Institute of Singapore (RRIS)

    collaborator UNKNOWN

  • Tan Tock Seng Hospital

    lead OTHER

Principal Investigators

  • Karen Chua · Tan Tock Seng Hospital

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06073106 on ClinicalTrials.gov